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Protease nexin-1, an inhibitor of serine proteases,
plays important parts in the regulation of the growth,
differentiation, and death of cells by modulating pro-
teolytic activity. The mRNA for protease nexin-1
accumulates in rat dermal papilla cells in a hair cycle-
dependent fashion and its levels are well correlated
with the ability of dermal papilla cells to support hair
growth. In an attempt to characterize the potential
role of protease nexin-1 as a modulator of hair growth
in humans, we investigated the steady-state level of
protease nexin-1 mRNA in cultured human dermal
papilla cells using a semiquantitative technique that
involved reverse transcription and polymerase chain
reaction, as well as the localization of this mRNA
A hair follicle is an attractive model for studies ofepithelial–mesenchymal interactions and growthregulation as it normally undergoes cyclic growth.During the growing phase (anagen) of the haircycle, keratinocytes in the bulbar region of the hair
follicle, termed matrix cells, actively proliferate to give rise to the
hair shaft and inner and outer root sheath cells. As the follicle
enters a regressing phase (catagen), cells in the lower portion of
the follicular epithelium cease to divide and then degenerate. After
a resting phase (telogen), during which the cells in the permanent
portion of the follicle including the bulge remain, a new hair bulb
is produced, re-entering anagen (Hardy, 1992). Little is known,
however, about the mechanisms that regulate the hair cycle. There
are various types of cell in the hair follicle itself and mesenchymal
cells are closely associated with each hair follicle. Among these
various cells, dermal papilla cells (DPC) play a key part in hair
growth (Oliver, 1966a; Jahoda et al, 1984). They synthesize and
secrete various molecules during specific phases of the hair cycle
and are considered to control the cyclic growth of follicular
keratinocytes (Holbrook et al, 1993).
It was reported recently that the mRNA for protease nexin-1
(PN-1) is produced in large quantities by the DPC in rat hair
follicles during the growing phase, and it was proposed that PN-1
might be a modulator of hair growth (Yu et al, 1995). PN-1, also
known as ‘‘glia-derived nexin-1’’ is a potent inhibitor of serine
Manuscript received February 3, 1999; revised May 28, 1999; accepted
for publication June 1, 1999.
Reprint requests to: Dr. Tadashige Sonoda, Department of Dermatology,
Oita Medical University, 1-1 Idaigaoka, Hasama, Oita 879-5593, Japan.
E-mail: sonodat@oita-med.ac.jp
Abbreviations: DHT, dihydrotestosterone; DPC, dermal papilla cells;
PN-1, protease nexin-1.
0022-202X/99/$14.00 · Copyright © 1999 by The Society for Investigative Dermatology, Inc.
308
in vivo using dissected hair follicles. Protease nexin-
1 mRNA was expressed in all dermal papilla cells
examined, and it was also identified in the lower part
of the connective tissue sheath. Moreover, we found
that levels of protease nexin-1 mRNA were depressed
by dihydrotestosterone, the most potent androgen, in
cultured dermal papilla cells obtained from balding
scalp. Our results suggest that protease nexin-1 might
be a key molecule in the control of hair growth in
humans and, moreover, that the androgen-mediated
downregulation of the synthesis of protease nexin-1
might be associated with the progression of male-
pattern baldness. Key words: baldness/gene expression/
hair follicle. J Invest Dermatol 113:308–313, 1999
proteases, such as thrombin, urokinase, and plasmin (Scott et al,
1985). By modulating the proteolytic activity of such enzymes,
PN-1 regulates the growth and differentiation of cells in many
organs (Low et al, 1982). Furthermore, expression of the gene for
PN-1 is regulated by androgen in murine seminal vesicles (Vassalli
et al, 1993). These results suggest that PN-1 might be critically
involved in the hair growth cycle, and they prompted us to
investigate the biologic role of PN-1 in human hair follicles. The
biologic role of PN-1 in hair follicles has thus far not been studied
in humans, only in rats. This study is the first report about PN-1
in human hair follicles.
In this study, we monitored the expression of mRNA for PN-1
in cultured human DPC. We also examined whether the expression
of this mRNA was affected by androgen, using DPC obtained
from balding scalp, as it is well known that androgen plays a
central part in the development of male-pattern baldness (Randall
et al, 1993).
MATERIALS AND METHODS
Isolation and culture of DPC DPC were isolated from scalp hair
follicles of anagen stage and cultured as described previously (Itami et al,
1991). In brief, dermal papillae were isolated from the bulbs of dissected
hair follicles under a binocular microscope, transferred to a tissue culture
dish and allowed to grow as explants for about 2 wk before the first
passage. The cells were maintained in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum, 20 mM L-glutamine, 50 units
per ml penicillin, and 50 µg per ml streptomycin in a humidified atmosphere
of 5% CO2 in air at 37°C. The medium was changed every third day.
Skin samples were obtained from 12 male patients (21–63 y old) who
were undergoing plastic surgery for treatment of male-pattern baldness
or resection of benign tumors. The samples were taken from the balding
(n 5 5) and occipital (n 5 4) scalp (balding and nonbalding donors) and
from the beard region (nonbalding donors) (n 5 3). Confluent cells after
four to six passages were used in this study. Ages of individuals, balding or
nonbalding and donor site are shown in Table I.
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Table I. Cultured human dermal papilla cells used in this
studya
Donor Age (y) Donor site Passage No.
1 (B) 33 F (B) 5
2 (B) 44 F (B) 5
3 (B) 35 P (B) 5
4 (B) 37 P (B) 5
5 (B) 44 F (B) 5
6 (B) 50 O (NB) 6
7 (B) 63 O (NB) 5
8 (NB) 21 O (NB) 4
9 (NB) 53 O (NB) 6
10 (NB) 27 Be (NB) 6
11 (NB) 24 Be (NB) 4
12 (NB) 21 Be (NB) 4
aAll donors were male. B, balding; NB, nonbalding; F, frontal; P, parietal; O,
occipital; Be, beard.
Effects of dihydrotestosterone (DHT) on expression of the mRNA
for PN-1 Confluent DPC were cultured with Dulbecco’s modified
Eagle’s medium that contained 1% fetal bovine serum for 24 h and then
for a further 24 h in Dulbecco’s modified Eagle’s medium that contained
1% fetal bovine serum and 10–8 M DHT.
Extraction of RNA Total RNA was extracted from cells and tissues
with ISOGEN (Nippon Gene, Tokyo, Japan). It was dissolved in double-
distilled water that had been treated with diethyl pyrocarbonate and stored
at –70°C prior to analysis.
Reverse transcription–polymerase chain reaction (reverse transcrip-
tion–PCR) cDNA was synthesized from 1 µg of total RNA. Total
RNA was heated to 70°C for 10 min in 17 µl of double-distilled water
that had been treated with diethyl pyrocarbonate that contained 0.5 µg of
oligo(dT)15 primer. After chilling on ice for 2 min, the following mixture
was added in a total volume of 40 µl: 400 units of Moloney Murine
Leukemia Virus Reverse Transcriptase (GIBCO BRL, Tokyo, Japan),
1 unit of RNase inhibitor and 0.5 mM each dNTP in reverse transcription
buffer, which consisted of 10 mM Tris–HCl, 50 mM KCl, 5 mM MgCl2,
and 3 mM dithiothreitol (pH 8.3). The final mixture was incubated at
42°C for 1 h and then the enzyme was inactivated by heating at 90°C for
5 min. Amplification by PCR was performed, in a thermal cycler, in a
final volume of 25 µl of a solution that contained 0.65 units of Taq
polymerase (GIBCO BRL), 200 µM dNTPs, 0.5 µM each specific primer,
and 0.5 µl cDNA template, in PCR buffer that consisted of 50 mM KCl,
10 mM Tris–HCl (pH 9) and 1.5 mM MgCl2. The nucleotide sequences
of the sense and anti-sense primers for synthesis of PN-1 cDNA were
59-GCGTAAATGGAGTTGGTAAA-39 and 59-GTCTATGGTCTTG-
GTGCTGA-39, respectively. For synthesis of glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) cDNA, the sense primer was 59-CCCATCACC-
ATCTTCCAG-39 and the anti-sense primer was 59-CCTGCTTCACCA-
CCTTCT-39. Expected sizes of the amplified fragments of PN-1 cDNA
and GAPDH cDNA were 584 and 577 base pairs, respectively. Amplifica-
tion was carried out for 25 cycles using a step-cycle program that consisted
of denaturation (94°C; 1 min), annealing (55°C; 1 min) and extension
(72°C; 1 min). In addition, the first denaturation step was allowed to
proceed for 5 min and the final extension was allowed to proceed for
3 min. To exclude possible amplification by contaminating genomic
DNA, PCR was performed with the extracted RNA itself instead with
cDNA templates.
Quantitation of products of reverse transcription–PCR After PCR,
10 µl of each reaction mixture were subjected to electrophoresis on a 1.5%
agarose gel that contained 0.5 µg per ml ethidium bromide in 1 3 Tris-
acetate electrophoresis buffer. The gel was photographed under ultraviolet
light and the intensity of each band was determined with a densitometer.
The levels of expression of PN-1 mRNA were normalized with respect
to levels of GAPDH mRNA.
Northern blotting analysis Eight micrograms of total RNA were
fractionated on a 1.5% agarose/formaldehyde gel and transferred to a nylon
membrane (Hybond N1; Amersham Pharmacia Biotech, Tokyo, Japan).
Hybridization with a digoxigenin-labeled DNA probe was allowed to
proceed overnight at 45°C. To obtain the probe, we purified PN-1 cDNA
Figure 1. Expression of PN-1 mRNA in cultured DPC from balding
scalp, as determined by reverse transcription–PCR. The expected
size of the product of PCR was 584 bp (lane 1). When the product of
PCR was digested with BamH1 (lane 2) and with Hinf1 (lane 3), two
fragments of the expected respective sizes (183 and 401 bp for BamH1,
202 and 382 bp for Hinf1) were obtained. PN-1 mRNA was also detected
by reverse transcription–PCR in whole hair follicles (lane 4). M, Size
markers. The donor was no. 1 in Table I.
after PCR from the band on the agarose gel using GFX PCR DNA and
Gel Band Purification Kit (Amersham Pharmacia Biotech) and then we
labeled the cDNA with digoxigenin-11-dUTP by random priming with
DIG-High Prime (Boehringer Mannheim, Tokyo, Japan). Chemilumines-
cent signals were detected with a DIG Luminescent Detection Kit
(Boehringer Mannheim).
Statistical analysis The results were compared by the Mann–Whitney
U test. p , 0.05 were taken as evidence of statistical significance.
Cyproterone acetate Cyproterone acetate was a generous gift from
Schering AG (Berlin, Germany).
RESULTS
We performed reverse transcription–PCR on DPC in culture for
amplifying PN-1 cDNA. The size of the product of reverse
transcription–PCR corresponded to the size expected for PN-1
cDNA (Fig 1, lane 1). This product was digested with two
restriction enzymes, BamH1 (lane 2) and Hinf1 (lane 3), and
fragments of the expected sizes were obtained. The identity of the
PN-1 cDNA was confirmed by Southern blotting analysis with a
specific oligonucleotide probe designed to hybridize to a region of
PN-1 cDNA between the sequences that corresponded to the two
primers (data not shown). PN-1 cDNA was also amplified to a
detectable level when we used whole hair follicles (lane 4). The
results clearly indicated that PN-1 mRNA was expressed in both
human cultured DPC and in intact hair follicles.
We assessed steady-state levels of PN-1 mRNA in cultured DPC
by a semiquantitative reverse transcription–PCR technique. As
shown in Fig 2, the intensity of each band on the gel was well
correlated with the amount of cDNA template used over a 100-
fold range of concentrations for both PN-1 and GAPDH after 25
cycles of amplification by PCR.
We compared levels of expression of PN-1 mRNA among DPC
from balding scalp, occipital scalp, and the beard region (Fig 3).
PN-1 mRNA was detected in all DPC examined and there were
no significant differences in levels.
To investigate the effect of androgen on the expression of PN-
1 mRNA, we cultured DPC for 24 h in the presence and in the
absence of 10–8 M DHT, which is known to be physiologically
the most potent androgen (Grino et al, 1990). Then we compared
the levels of PN-1 mRNA between DHT-treated and control cells
by semiquantitative reverse transcription–PCR (Fig 4). The level
of PN-1 mRNA was significantly depressed upon treatment of
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Figure 2. Semiquantitative analysis by reverse transcription–PCR
of the expression of PN-1 mRNA. After 25 cycles of amplification, the
intensity of the band of product on the gel, as measured with a densitometer,
was well correlated with the amount of cDNA template over a 100-fold
range of concentrations for both PN-1 cDNA and GAPDH cDNA. The
number at the top of each lane represents the relative amount of cDNA
template in the reaction mixture that was subjected to reverse transcription–
PCR. The numbers on the left indicate the number of cycles of PCR.
The donor was nos 1 and 4 in Table I for GAPDH and PN-1, respectively.
Figure 3. Regional variations in the expression of PN-1 mRNA,
as determined by semiquantitative reverse transcription–PCR. RNA
was extracted from DPC from the indicated areas of skin. Each point
represents the ratio of levels of expression of PN-1 mRNA and GAPDH
mRNA. Bars indicate average values for each group. There is no significant
difference among the three groups.
DPC from balding scalp with DHT, but levels were unchanged by
DHT when cells were derived from occipital scalp or the beard
region. The reduced level of PN-1 mRNA caused by DHT in
DPC from balding scalp returned to the control level after the
addition of cyproterone acetate, an antiandrogen, which interferes
binding of androgen to its receptor, to the culture medium (Fig 5).
Thus, an inhibitory action of DHT on PN-1 mRNA expression
was considered to be exerted via androgen receptor pathway.
Cyproterone acetate itself did not affect the expression of PN-1
mRNA in the cells from balding scalp (data not shown). In the
case of cells from occipital scalp, expression was unaffected by the
addition of DHT and/or cyproterone acetate. In order to exclude
possible amplification of nonspecific mRNAs, amplified products
after 14 cycles of reverse transcription–PCR was transferred to the
membrane and were detected by Southern blotting analysis. The
results confirmed inhibitory effect of DHT on PN-1 mRNA
expression and restoration of its level by cyproterone acetate in
DPC from balding scalp (data not shown).
We next examined the effect of the concentration of DHT and
the duration of incubation on the expression of PN-1 mRNA by
DPC from balding scalp. The expression of PN-1 was reduced by
DHT in a concentration-dependent manner, with a maximal effect
Figure 4. The effects of DHT on the expression of PN-1 mRNA.
DPC from the indicated regions were incubated in the presence and in
the absence of 10–8 M DHT for 24 h. The level of expression of PN-1
mRNA was normalized against that of GAPDH mRNA. Each point
represents a percentage relative to the control value (incubation in the
absence of DHT). Bars indicate average values.
Figure 5. The effects of an antiandrogen on the DHT-mediated
suppression of the expression of PN-1 mRNA. DPC from balding
and occipital scalp (donor 1) were incubated with 10–8 M DHT in the
presence and in the absence of cyproterone acetate (CA; 10–7 M) for 24 h.
C, Control; D, with DHT; D 1 CA, with DHT and CA. This experiment
was performed three times with similar results.
Figure 6. The effects of increasing concentrations of DHT on the
expression of PN-1 mRNA by DPC from balding scalp. The results
shown are representative of results of two experiments, using DPC from
the same donor (no. 1 in Table I). DPC were treated with various
concentrations of DHT for 24 h before RNA extraction. Results for PN-
1 mRNA were calculated relative to those for GAPDH mRNA and then
normalized relative to the control value (no DHT). Each value represents
single determination.
at 10–7 M (Fig 6). Furthermore, the expression of PN-1 mRNA
decreased within 4 h of exposure to 10–8 M DHT and then
gradually returned to the control level (Fig 7).
In order to confirm the results obtained by semiquantitative
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Figure 7. Time-course of the expression of PN-1 mRNA in DPC
from balding scalp upon treatment with 10–8 M DHT. The relative
level of PN-1 mRNA immediately before treatment with DHT was taken
as 1.0. The results represent averages 6 SD of results of three independent
experiments with DPC derived from donor 1.
reverse transcription–PCR, we analyzed the expression of PN-1
mRNA by northern blotting analysis of RNA from DHT-treated
DPC from balding scalp. The DPC treated with DHT clearly
expressed a lower level of PN-1 mRNA than the untreated DPC
(Fig 8). By contrast, GAPDH mRNA was detected at similar levels
in both samples, and the respective intensities of two sharp bands
of 28S and 18S ribosomal RNA were also similar.
In order to examine the localization of PN-1 mRNA, we
isolated 30 hair follicles from balding and from nonbalding scalp
skin and dissected each hair follicle into five parts under a microscope
(Fig 9a). First, hair follicles were cut horizontally right above the
tip of dermal papilla. Then, from the bulbar portion the connective
tissue sheath was inverted, and the matrix portion was dissected
from dermal papilla. It was probable that the dermal papilla was
contaminated with a few matrix cells. The dermal papilla was then
detached from the connective tissue at the base of the papilla
(Fig 9b). As we could easily detect the constriction between these
two components (Fig 9b), contamination of each other was
considered minimal. Secondly, the remaining upper portion of the
hair follicles was further divided into an epithelial compartment,
which included the hair shaft and both inner and outer root sheaths,
and connective tissue sheath. It was easy to mechanically separate
these two components. Histologic examination confirmed that
there was no contamination between the two components (Fig 9d,
e). We then extracted total RNA from the pooled samples of
dermal papilla [Fig 9a (4) and b], the lower part of the connective
tissue sheath [Fig 9a (3) and b], the upper part of the connective
tissue sheath [Fig 9a (2) and e], the epithelial compartment that
surrounded the dermal papilla and included the hair matrix [Fig 9a
(5)], and the upper epithelial component [Fig 9a (1) and d], which
was mainly composed of the inner and outer root sheaths. Then
reverse transcription–PCR of PN-1 was performed with each
sample of RNA for 30 cycles (Fig 10). The expression of GAPDH
mRNA in each sample was examined by reverse transcription–
PCR for 30 cycles with the serially diluted cDNA. Then the
cDNA with a similar level of expression of GAPDH mRNA
among the five-pooled samples were used for the analysis of PN-
1. Sharp bands of the expected product were obtained from most
pooled samples of dermal papilla, some of the lower connective
tissue sheath and two upper connective tissue sheath, but hardly
from epithelial components.
DISCUSSION
In this study we found that PN-1 mRNA was expressed by cultured
human DPC. In addition, the expression in the dermal papilla and
Figure 8. Northern blotting analysis of the expression of PN-1
mRNA after treatment of DPC from balding scalp with DHT. DPC
from balding scalp (no. 1 in Table I), in which expression of PN-1 mRNA
was maximally affected by DHT as shown in Fig 4, were incubated in
the presence and in the absence of 10–8 M of DHT for 24 h. Eight
micrograms of total RNA were loaded in each lane. After electrophoresis,
RNA was transferred to a nylon membrane and allowed to hybridize with
digoxigenin-labeled probes for PN-1 mRNA and GAPDH mRNA. Bands
of 28S rRNA and 18S rRNA are shown as controls for loading of equal
amounts of RNA in each lane.
lower connective tissue sheath was confirmed by analysis of mRNA
from dissected hair follicles. In rats, PN-1 mRNA accumulates
specifically in the DPC of the hair follicle, and is not detected in
any other follicular cells, such as the cells of the connective tissue
sheath. In addition, in the rat, the level of expression is strictly
anagen dependent (Yu et al, 1995). Further studies are required to
determine whether such hair cycle-dependent changes in levels of
PN-1 mRNA occur in human DPC and cells of the lower
connective tissue sheath. The expression of PN-1 mRNA in the
latter mesenchymal component seems to be of particular interest
as this component from the rat is able to regrow whisker hairs
even when the dermal papilla has been removed (Oliver, 1966b).
PN-1 regulates cell growth and differentiation via inhibition of
certain proteases, and its effect is modulated by components of the
extracellular matrix such as heparan sulfate proteoglycan (Farrell
and Cunningham, 1987) and type IV collagen (Donovan et al,
1994). Thus, the action of PN-1 might be modulated by variations
in the amounts of components of the extracellular matrix that are
synthesized by DPC during the hair cycle (Messenger et al, 1991).
Yu et al (1995) demonstrated that the level of expression of PN-
1 mRNA in a series of lines of DPC was well correlated with the
ability of each cell line to support hair growth, suggesting that PN-
1 might be a potential modulator of hair growth. In this study,
however, we did not detect any significant differences in levels of
PN-1 mRNA between follicles from balding scalp and the beard
region or occipital scalp. Using semiquantitative reverse transcrip-
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Figure 9. Five compartments dissected from a hair
follicle. Each hair follicle was dissected into five parts
under a microscope (a). 1, upper epithelial compartment
which included hair shaft and inner and outer root sheath;
2, upper connective tissue sheath; 3, lower connective
tissue sheath; 4, dermal papilla; 5, epithelial compartment
surrounding dermal papilla. The connective tissue sheath
(CTS) of the bulbar region was inverted, and the dermal
papilla (DP) was then cut at its base (b). Note that almost
all epithelial portions surrounding the dermal papilla were
removed. The adhesion between outer root sheath and
connective tissue sheath (arrow) was loose enough for
mechanical separation (c). The vertical section of the
separated epithelial compartment in (c) shows that there is
no contamination of the outer connective tissue (d). The
transverse section of the outer connective tissue also shows
there is no contamination of the epithelial compartment
(e). Scale bars: 100 µm.
Figure 10. Localization of PN-1 mRNA in hair
follicles from the scalp. Thirty hair follicles were
isolated from each scalp skin sample derived from male
balding donors and were dissected into five parts: (a)
upper connective tissue sheath; (b) upper epithelial
compartment; (c) epithelial compartment surrounding
dermal papilla; (d) lower connective tissue sheath; and
(e) dermal papilla. Numbers on the left line represent
the ages of individuals (in years). P, parietal; F, frontal;
O, occipital; T, temporal; B, balding area.
tion–PCR and northern blotting analysis, we showed that the
steady-state level of PN-1 mRNA in DPC from the balding scalp
region was depressed by DHT, although the extent of depression
by DHT varied considerably among individual samples. It is
well known that only genetically predisposed individuals develop
androgenic alopecia (Hamilton, 1942). If DHT and androgen
receptors play a key part in the development of male-pattern
baldness, it is possible that several specific molecules that are
synthesized by DPC and whose production is regulated by androgen
at the transcriptional level might mediate the action of androgen
to miniaturize hair follicles. The androgen-induced downregulation
of the expression of PN-1 might be one possible mechanism that
leads to miniaturization of these follicles.
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